产品名称
16:0 lyso PC-d49, powder
SMILES string
[O-]P(OC([2H])([2H])C([2H])([2H])[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])(OC([2H])([2H])[C@]([2H])(O)C([2H])([2H])OC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C
assay
99% (TLC)
form
powder
packaging
package of 1 × 1 mg (870308P-1MG), package of 1 × 5 mg (870308P-5MG)
manufacturer/tradename
Avanti Research™ - A Croda Brand
shipped in
dry ice
storage temp.
−20°C
General description
16:0 Lyso PC-d49 (1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (d49) is a deuterated derivative of 16:0 Lyso PC. Lyso PC is obtained from the hydrolysis of phosphatidylcholine (PC) by phospholipase A.
Packaging
5 mL Amber Glass Screw Cap Vial (870308P-1MG)
5 mL Amber Glass Screw Cap Vial (870308P-5MG)
5 mL Amber Glass Screw Cap Vial (870308P-5MG)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine (lysoPC) in ovarian cancer patients
Okita M, et al.
International Journal of Cancer. Journal International Du Cancer, 71(1), 31-34 (1997)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持